Scopus Eşleşmesi Bulundu
6
Atıf
30
Cilt
3339-3349
Sayfa
Özet
Background: Microvascular dysfunction develops in tissues after Ischemia-Reperfusion (IR). The current study aimed to determine the effect of naringin supplementation on kidney caspase-3, IL-1β, and HIF-1α levels and kidney histology in rats undergoing unilateral nephrectomy and kidney-ischemia reperfusion. Methods: The study was conducted on 8-12 weeks old 40 Wistar-type male rats. Experimental renal ischemia-reperfusion and unilateral nephrectomy were performed under general anesthesia in rats. Experimental groups were formed as follows: 1-Control group, 2-Sham control + Vehicle group, 3- Renal ischemia-reperfusion (Renal I+R) + Vehicle group, 4-Renal I+R + Naringin (50 mg/kg/day) group (3 days application) group, 5-Renal I+R + Naringin (100 mg/kg/day) group (3 days supplementation). Nephrectomy in the left kidneys and the ischemia for 45 minutes and reperfusion in the right kidneys followed by 72 hours of reperfusion. Naringin was administered intraperitoneally at the beginning of the reperfusion, 24 hours and 48 hours later. At the end of the experiments, blood was first taken from the heart in animals under general anesthesia. Then, the animals were killed by cervical dislocation, and kidney tissue samples were taken. Tissues were evaluated for caspase-3, IL-1β, and HIF-1α as well as histologically. Results: As a result of ischemia in kidney tissues, HIF-1α decreased, while caspase-3 and IL-1β increased. IR also caused damage to the kidney tissue. However, naringin supplementation corrected the deterioration to a certain extent. Conclusion: The results of the study showed that naringin may have protective effects on kidney damage due to anti-inflammatory and antiapoptosis mechanisms caused by unilateral nephrectomy and IR in rats.
Web of Science Eşleşmesi Bulundu
7
WoS Atıf
30
Cilt
Article
Belge Türü
Kaynak: CURRENT PHARMACEUTICAL DESIGN
· s. 3339-3349
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 6.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2024 yılı verileri
Current Pharmaceutical Design
Q2
SJR Quartile
0,611
SJR Skoru
190
H-Index
🔓
Açık Erişim
Kategoriler: Drug Discovery (Q2) · Pharmacology (Q2)
Alanlar: Pharmacology, Toxicology and Pharmaceutics
Ülke: United Arab Emirates
· Bentham Science Publishers
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Current Pharmaceutical Design
ISSN
1381-6128
Yıl
2024
/ 1. ay
Cilt / Sayı
30
/ 41
Sayfalar
3339 – 3349
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q2
Teşvik Puanı
2,40
· YÖKSİS Akademik Teşvik
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
6 kişi
Erişim Türü
Basılı
Alan
Sağlık Bilimleri Temel Alanı
Fizyoloji
YÖKSİS Yazar Kaydı
Yazar Adı
DANIŞ ESRA GÜLSÜM,ACAR GÖZDE,DAŞDELEN DERVİŞ,Solmaz Merve,MOĞULKOÇ RASİM,BALTACI ABDULKERİM KASIM
YÖKSİS ID
8216067